Table 2

Participant characteristics relating to AFO, by region and sex (figures are in percentage of total unless stated)

MenWomen
RuralUrbanOverallRuralUrbanOverall
Total118 83791 220210 057167 727134 711302 438
Mean age (years)52.653.152.950.552.651.5
AFO GOLD stage I–IV8.44.56.75.53.34.4
AFO GOLD stage II–IV7.03.65.54.62.43.5
AFO LLN9.24.87.37.74.86.3
Classification of severity of AFO (values are % predicted)*
Mild (FEV1 ≥80%)1.40.91.20.90.91.4
Moderate (50% ≤ FEV1 ≥80%)4.22.43.42.91.74.2
Severe (50% ≤ FEV1 ≥80%)2.21.01.61.40.62.2
Very severe (FEV1 <80%)0.70.30.50.30.10.7
Doctor diagnosed CB/E3.22.93.12.12.42.2
Doctor diagnosed CB/E and still on treatment34.828.432.137.827.432.7
Doctor diagnosed CB/E and
 AFO GOLD stage I–IV†40.522.833.131.514.323.0
 AFO GOLD stage II–IV†39.621.732.230.412.921.7
 AFO LLN†39.522.032.335.616.726.3
Under diagnosis86.186.686.290.391.590.7
Over diagnosis60.578.067.764.483.373.7
Doctor diagnosed asthma0.40.80.60.30.80.5
Breathlessness‡5.83.44.78.54.76.8
Chronic cough§6.84.55.83.01.82.4
Chronic cough and sputum¶7.36.26.82.61.82.2
Chronic cough with sputum and
 AFO GOLD stage I–IV**17.39.814.417.58.414.1
 AFO GOLD stage II–IV**15.88.613.115.87.212.7
 AFO LLN**18.910.115.520.810.016.9
  • p Value for difference between urban and rural <0.0001 except men: doctor-diagnosed CB/E (p=0.0002); underdiagnosis (p=0.3775) women: underdiagnosis (p=0.0032).

  • *Based on prebronchodilator FEV1 in participants with FEV1/FVC <0.70 according to modified GOLD definition.

  • †Figures are percentage of different GOLD stages of AFO or LLN based AFO in those with doctor diagnosed CB/E.

  • ‡Becomes short of breath while walking on level ground with healthy people of same age.

  • §Had cough for at least 3 months in the past 12 months.

  • ¶Cough up sputum in the morning for at least 3 months in the past 12 months.

  • **Figures are percentage of different GOLD stages of AFO or LLN based AFO in those with chronic cough and sputum.

  • AFO, air flow obstruction; CB/E, chronic bronchitis/emphysema; FEV1, forced expiratory volume in 1 s; GOLD, Global Initiative for Obstructive Lung Disease; LLN, lower limit of normal.